Skip to content

Effect of Three Modalities of Spontaneous Breathing Tests on Respiratory Efforts in Tracheostomized Patients

Effect of Three Modalities of Spontaneous Breathing Tests on Respiratory Efforts in Tracheostomized Patients. Monocentric Crossover Interventionnal Study.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03856424
Acronym
TWEEP
Enrollment
18
Registered
2019-02-27
Start date
2019-03-08
Completion date
2023-12-30
Last updated
2022-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mechanical Ventilation Complication

Keywords

Ventilation, Tracheotomy, Difficult weaning, Spontaneous Breathing Test, Esophageal pressure, Work of breathing, Esophageal pressure time-product, Difficult weaning from mechanical ventilation, Ventilation weaning

Brief summary

Datas are lacking concerning weaning from mechanical ventilation for tracheostomized patients. In particular, the effect of different modalities of spontaneous breathing trials on respiratory effort has not been extensively described. This crossover physiology study will include 18 tracheostomized patients ventilated for more than 72 hours. The objective of this study is to compare the effect of three different modalities of SBTs on respiratory effort in tracheostomized patients. The modalities tested are : Pressure Support Ventilation (PSV level 5 cmH2O, PEEP 5 cmH2O), T-piece test and high-flow Oxygen. Each modality is applied in a randomized order, during 30 minutes. During every modality tested, esophageal and gastric pressure, expired CO2, and comfort will be monitored, in addition to standard monitoring. Based on esophageal pressure monitoring, patient's respiratory efforts can be calculated either by esophageal pressure-time product and work of breathing. Pressure generated by inspiratory muscles will also be assessed.

Interventions

PROCEDUREModality 1

Pressure support ventilation (PSV) modality

PROCEDUREModality 2

T-Piece modality

PROCEDUREModality 3

High-flow oxygen

Sponsors

Piquilloud Imboden Lise
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Intervention model description

Three different spontaneous breathing trials modalities will be tested in each patient in a randomized order. Washout periods will be performed between the tested modalities.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients for whom a tracheostomy is planned * Patients on invasive ventilation for \>72 hours

Exclusion criteria

* Tracheostomy for upper airway obstruction or other disease * Patients tracheostomized before current hospitalization * Patients with Glasgow Coma Scale (GCS) \< 8/10 after cardiac arrest * Patients with GCS \< 8/10 because of primary central neurologic disease * Patients for whom therapeutic limitations have already been decided * Patients for whom weaning from ventilation is not an objective * Patients suffering from myasthenia gravis * Patients with cardiac assistance device * Patients with medullary lesion proximal to C5 * Patients for whom nasogastric tube insertion is contraindicated

Design outcomes

Primary

MeasureTime frameDescription
Evolution of pressure-time product of esophageal pressureRecorded every 5 minutes during each sequence and washout period, 180 minutesQuantification of inspiratory effort of the patient

Secondary

MeasureTime frameDescription
Evolution of esophageal pressure dropRecorded every 5 minutes during each sequence and washout period, 180 minutesMaximum variation of esophageal pressure during respiratory cycles
Evolution of inspiratory muscle pressure (Pmus)Recorded every 5 minutes during each sequence and washout period, 180 minutesPressure generated by patients' respiratory muscles
Evolution of transdiaphragmatic pressure (Ptransdiaph)Recorded every 5 minutes during each sequence and washout period, 180 minutesDifference between gastric and esophageal pressure. Reflect of pressure generated by diaphragm during inspiration
Evolution of tidal volume (VT)Recorded every 5 minutes during each sequence and washout period, 180 minutes
Evolution of respiratory rate (RR)Recorded every 5 minutes during each sequence and washout period, 180 minutes
Evolution of inspiratory airway flowRecorded every 5 minutes during each sequence and washout period, 180 minutes
Evolution of ratio of inspiratory time over total duration of a breathing cycle (ti/ttot)Recorded every 5 minutes during each sequence and washout period, 180 minutes
Evolution of Rapid Shallow Breathing Index (RSBI)Recorded every 5 minutes during each sequence and washout period, 180 minutesRR/VT - predictor during ventilation weaning of intolerance of SBT
Evolution of respiratory system compliance (Crs)Recorded every 5 minutes during each sequence and washout period, 180 minutesCapacity of total respiratory system to gain volume for a given pressure
Evolution of lungs compliance (CL)Recorded every 5 minutes during each sequence and washout period, 180 minutesCapacity of lungs to gain volume for a given pressure
Evolution of chest wall compliance (Ccw)Recorded every 5 minutes during each sequence and washout period, 180 minutesCapacity of lungs to gain volume for a given pressure
Evolution of transpulmonary pressure (Ptranspulm)Recorded every 5 minutes during each sequence and washout period, 180 minutesAlveolar pressure minus pleural pressure
Evolution of ratio of total dead space volume over tidal volumeRecorded every 5 minutes during each sequence and washout period, 180 minutesCalculated by means of expired CO2 and arterial blood gas CO2
Evolution of work of breathing (WOB)Recorded every 5 minutes during each sequence and washout period, 180 minutesTotal area of a Campbell diagram for esophageal pressure and volume during one respiratory cycle
Evolution of total Positive End-Expiratory Pressure (PEEPtot)Recorded every 5 minutes during each sequence and washout period, 180 minutesAirway pressure during end-expiratory ventilator occlusion
Evolution of heart rateRecorded every 5 minutes during each sequence and washout period, 180 minutesStandard monitoring
Evolution of blood pressureRecorded every 5 minutes during each sequence and washout period, 180 minutesStandard monitoring
Evolution of Plateau pressure (Pplat)Recorded at minute 1 and minute 30 of each three spontaneous Breathing Trial, 90 minutesAirway pressure during end-inspiratory ventilator occlusion (corresponds to alveolar pressure)
Evolution of intrinsic Positive End-Expiratory Pressure (PEEPi)Recorded at minute 1 and minute 30 of each three spontaneous Breathing Trial, 90 minutesPEEPi minus PEEP set on ventilator
Pulmonary strainRecorded every 5 minutes during each sequence and washout period, 180 minutesMeasured as the ratio of tidal volume over functionnal residual capacity (FRV)
Evolution of Diaphragmatic excursion (DE)Recorded at minute 1 and minute 30 of each three spontaneous Breathing Trial, 90 minutesUltrasound measurement of diaphragm movement during inspiration
Evolution of Diaphragmatic thickening fraction (DTF)Recorded at minute 1 and minute 30 of each three spontaneous Breathing Trial, 90 minutesUltrasound measurement of diaphragm thickening during inspiration
Evolution of hematocritsRecorded at minute 30 of each three spontaneous Breathing Trial, 90 minutesMesured by arterial blood
Evolution of Richmond Agitation/Sedation scale (RASS) scoreRecorded at minute 1 and minute 30 of each three spontaneous Breathing Trial, 90 minutesUsed in ICU to monitor neurologic changes in patients. Scale from -5 (unarousable) to +4 (combative). 0 is a calm and responsive patient.
Evolution of Borg dyspnea scale scoreRecorded at minute 1 and minute 30 of each three spontaneous Breathing Trial, 90 minutesNumeric scale to quantify dyspnea from 0 to 10. 0 mean patient does not feel that breathing is difficult and 10 is a maximal dyspnea. Measured twice during each Spontaneous Breathing Trial
Evolution of Multidimensionnal dyspnea scale (MDP) scoreRecorded at minute 30 of each three spontaneous Breathing Trial, 90 minutesScore to quantify comfort, dyspnea and assess respiratory effort as perceived by patient. This scale contains multiple items, divided in two dimensions : sensory and affective. Sensory dimension contains : intensity on a scale of 0 to 10 of five sensory qualities (physical breathing effort, air hunger, tightness, mental breathing effort, hyperpnoea) Affective dimension contains : a breathing discomfort scale (scale of 0 to 10) Measured once during each Spontaneous Breathing Trial
Evolution of total dead space volumeRecorded every 5 minutes during each sequence and washout period, 180 minutesCalculated by means of expired CO2

Countries

Switzerland

Contacts

Primary ContactLise Piquilloud Imboden, MER&PD
lise.piquilloud@chuv.ch+41 79 556 68 27
Backup ContactDavy Cabrio
davy.cabrio@chuv.ch+41 79 556 69 56

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026